The $50 million fundraise will be used to expand Viz.ai’s technology both physically and in terms of the disease states it can address, Dr. Chris Mansi, the startup’s CEO, said in a news release.
The company’s flagship software, which uses deep learning to transmit information about suspected acute ischemic stroke patients directly to specialists for treatment, is currently available in more than 300 hospitals in the U.S., including New York City-based Mount Sinai Health System and Winston-Salem, N.C.-based Novant Health.
More articles on AI:
Novant Health implements tech to speed stroke diagnosis
DOD developing algorithm to detect, reduce spread of disease
Houston Methodist deploys AI platform to streamline patient-provider interactions
